Learn More
Medchemexpress LLC Astragaloside IV | 84687-43-4 | 784.97 | 1 ML

Supplier: Medchemexpress LLC HYN043110MM/1ML
Astragaloside IV, an active component isolated from *Astragalus membranaceus*, suppresses the activation of ERK1/2 and JNK, and downregulates matrix metalloproteases (MMP)-2, (MMP)-9 in MDA-MB-231 breast cancer cells.
- Suppresses ERK1/2 and JNK activation
- Downregulates matrix metalloproteases (MMP)-2 and (MMP)-9
- Inhibits NSCLC cell growth and increases chemosensitivity to cisplatin
- Inhibits viability and invasive potential of MDA-MB-231 breast cancer cells
- Prevents cognitive deficits from cerebral ischemia and reperfusion
- Decreases cytokine levels and inhibits TLR4 pathways
- Attenuates NLRP3 and cleaved-caspase-1 expression
- Reduces serum ALT/AST levels and liver apoptosis
- Increases 48-hour survival rate in mice
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.